Kala Bio (KALA) EBT Margin (2019 - 2022)
Kala Bio's (KALA) quarterly EBT Margin came in at 3757.62% in Q3 2022, down 284053.0% year-over-year from N/an in Q3 2021, and down 180.71% quarter-over-quarter from 1338.62% in Q2 2022.
Powered by 
Analysis
Kala Bio (KALA) EBT Margin (2019 - 2022) Analysis & Trends
Kala Bio has disclosed EBT Margin across 4 years of filings, most recently posting 3757.62% for Q3 2022.
- In Q3 2022, EBT Margin fell 284053.0% year-over-year to 3757.62%; the TTM figure through Dec 2022 stood at 2268.96% (down 103657.0% YoY), while the FY2022 annual figure was 2268.96%, down 103657.0% from the prior year.
- EBT Margin came in at 3757.62% for Q3 2022 at Kala Bio, down from 1338.62% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 917.09% in Q3 2021 to a low of 3757.62% in Q3 2022.
- Average EBT Margin over 4 years is 1796.27%, with a median of 1597.24% recorded in 2019.
- Year-over-year, EBT Margin jumped 177912 bps in 2021 and slumped 284053 bps in 2022.
- Over 4 years, EBT Margin stood at 1860.85% in 2019, then advanced by 25 bps to 1390.17% in 2020, then sank by 89 bps to 2633.57% in 2021, then plunged by 43 bps to 3757.62% in 2022.
- Per Business Quant data, the three most recent EBT Margin figures were 3757.62% in Q3 2022, 1338.62% in Q2 2022, and 2400.95% in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.55 Bn | 192.56 Bn | 7.24 Bn | 27.53% |
| 2 | Gilead Sciences | 180.15 Bn | 176.98 Bn | 6.22 Bn | -131.41% |
| 3 | Vertex Pharmaceuticals | 131.59 Bn | 123.73 Bn | 2.84 Bn | 41.75% |
| 4 | Regeneron Pharmaceuticals | 81.98 Bn | 73.98 Bn | 3.93 Bn | 35.61% |
| 5 | Argenx Se | 60.33 Bn | 55.14 Bn | 1.37 Bn | 35.78% |
| 6 | Moderna | 53.75 Bn | 48.61 Bn | 52.00 Mn | -528.97% |
| 7 | Alnylam Pharmaceuticals | 33.06 Bn | 29.76 Bn | 992.69 Mn | 13.77% |
| 8 | Biogen | 31.95 Bn | 30.67 Bn | 1.96 Bn | 4.84% |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | -20,427.46% |
| 10 | Kala Bio | 8.44 Mn | 8.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -3,757.62% |
| Jun 30, 2022 | -1,338.62% |
| Mar 31, 2022 | -2,400.95% |
| Dec 31, 2021 | -2,633.57% |
| Sep 30, 2021 | -917.09% |
| Jun 30, 2021 | -1,019.44% |
| Mar 31, 2021 | -931.17% |
| Dec 31, 2020 | -1,390.17% |
| Sep 30, 2020 | -1,258.92% |
| Jun 30, 2020 | -2,798.56% |
| Mar 31, 2020 | -2,049.95% |
| Dec 31, 2019 | -1,860.85% |
| Sep 30, 2019 | -1,597.24% |
| Jun 30, 2019 | -1,158.24% |
| Mar 31, 2019 | -1,831.75% |